CHONDROSPHERE (Spherox®)

Clinical Indication

Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee in adults

Comments

In line with NICE TA 508

 

Local guidance

Implementation date 7th June 2018

Date of classification

May 2018

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.